Drug Profile
Research programme: microRNA-based therapeutics - Groove Biopharma
Alternative Names: MGB; microRNA; mirinaLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Groove Biopharma
- Class MicroRNAs; Oligonucleotides; RNA binding proteins
- Mechanism of Action MicroRNA modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Fibrosis; Metabolic disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Cancer in USA
- 16 Jul 2016 No recent reports of development identified for research development in Fibrosis in USA
- 16 Jul 2016 No recent reports of development identified for research development in Metabolic-disorders in USA